摘要
目的分析莫西沙星治疗253例脑卒中相关性肺炎的疗效。方法应用盐酸莫西沙星氯化钠注射液400mg静脉滴注,每日1次,使用3～7 d,主要以临床疗效评价标准和细菌学评价标准为疗效观察指标,收集相关数据,进行统计处理。结果 253例早期脑卒中相关性肺炎患者经莫西沙星治疗总有效率达95.3%,细菌总清除率达84.2%。结论莫西沙星是临床治疗早期脑卒中相关性肺炎的有效抗菌药物之一。
Objective To evaluate the efficacy of moxifloxacin in the treatment of stroke associated pneumonia. Methods Moxi- floxacin hydrochloride injection （400 mg/day） was administered intravenously for 3 to 7 days. The data of bacteriology and clinical efficacy were collected and analyzed. Results The clinical efficacy was confirmed in 95.3% of the 253 cases of stroke-associated pneumonia after moxifloxacin therapy. The bacterial clearance rate was 84.2%. Conclusions Moxifloxacin is one of the effective therapies for early stroke-associated pneumonia.
出处
《中国感染与化疗杂志》
CAS
2011年第1期6-9,共4页
Chinese Journal of Infection and Chemotherapy
关键词
脑卒中相关性肺炎
莫西沙星
临床观察
stroke-associated pneumonia
moxifloxacin
clinical evaluation
